| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.84 (Beat by $0.13) |
| EPS GAAP Actual | $0.84 (Beat by $0.13) |
| Revenue Actual | $3.159B |
| Revenue Surprise | Beat by $3159M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.74125 |
| EPS GAAP Estimate | $0.74125 |
| Revenue Estimate | $3.10365B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2028 | 3.74 | 3.8 | 3.6748 | 3.80957 | 1 |
| Mar 2027 | 2.505 | 5.67 | 2.28174 | 2.85783 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.09 | 0.09 | 3.159B | -2.44% | 3159M |
| FQ1 2025 (Mar 2025) | 1.46 | 1.46 | 3.169B | -6.85% | 3169M |
| FQ4 2024 (Dec 2024) | -0.38 | -0.38 | 3.225B | -5.4% | 3225M |
| FQ3 2024 (Sep 2024) | 0.23 | 0.23 | 3.241B | -6.02% | 3241M |
| FQ2 2024 (Jun 2024) | 0.14 | 0.14 | 3.236B | -6.49% | 3236M |
| FQ1 2024 (Mar 2024) | -1.1 | -1.1 | 3.386B | -6.05% | 3386M |
| FQ4 2023 (Dec 2023) | 0.82 | 0.82 | 3.399B | -4.91% | 3399M |
| FQ3 2023 (Sep 2023) | 0.49 | 0.49 | 3.436B | -3.78% | 3436M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.74125
Consensus Revenue Estimates
3.10365B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.86 | -- | 0.85319 | 0.8674 | 4 |
| FQ4 2027 (Dec 2027) | 0.91 | -- | 0.90279 | 0.91783 | 7 |
| FQ3 2027 (Sep 2027) | 0.78 | -- | 0.75269 | 0.79096 | 4 |
| FQ2 2027 (Jun 2027) | 0.74 | -- | 0.71409 | 0.7504 | 3 |
| FQ1 2027 (Mar 2027) | 0.97 | -- | 0.96605 | 0.97791 | 3 |
| FQ4 2026 (Oct 2026) | 0.92 | -- | 0.8853 | 0.94699 | 3 |
| FQ3 2026 (Jul 2026) | 0.88 | -- | 0.84681 | 0.90582 | 4 |
| FQ2 2026 (Jun 2026) | 0.835 | 89.22 | 0.8316 | 0.84181 | 3 |
| FQ1 2026 (Mar 2026) | 1.12333 | -29.97 | 1.09112 | 1.14776 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 3.07B | -- | 3.05B | 3.09B | 2 |
| FQ4 2027 (Dec 2027) | 3.07B | -- | 3.05B | 3.09B | 3 |
| FQ3 2027 (Sep 2027) | 3B | -- | 2.92B | 3.03B | 3 |
| FQ2 2027 (Jun 2027) | 3B | -- | 2.92B | 3.03B | 3 |
| FQ1 2027 (Mar 2027) | 3.16B | -- | 3.15B | 3.18B | 1 |
| FQ4 2026 (Oct 2026) | 3.06B | -- | 2.97B | 3.13B | 4 |
| FQ3 2026 (Jul 2026) | 3B | -- | 2.91B | 3.07B | 4 |
| FQ2 2026 (Jun 2026) | 3.01B | -4.97 | 3B | 3.03B | 1 |
| FQ1 2026 (Mar 2026) | 3.25B | 2.54 | 3.18B | 3.31B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.09 | 0.09 | 100% | |
| FQ1 2025 (Mar 2025) | 1.46 | 1.46 | 100% | |
| FQ4 2024 (Dec 2024) | -0.38 | -0.38 | 100% | |
| FQ3 2024 (Sep 2024) | 0.23 | 0.23 | 100% | |
| FQ2 2024 (Jun 2024) | 0.14 | 0.14 | 100% | |
| FQ1 2024 (Mar 2024) | -1.1 | -1.1 | 100% | |
| FQ4 2023 (Dec 2023) | 0.82 | 0.82 | 100% | |
| FQ3 2023 (Sep 2023) | 0.49 | 0.49 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $3.16B | $3159M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.17B | $3169M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.23B | $3225M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.24B | $3241M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.24B | $3236M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.39B | $3386M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.4B | $3399M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $3.44B | $3436M | 100% |